nirogacestat

FDA Drug Profile — OGSIVEO

Drug Details

Generic Name
nirogacestat
Brand Names
OGSIVEO
Application Number
NDA217677
Sponsor
SpringWorks Therapeutics, Inc.
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
NIROGACESTAT

Indications and Usage

1 INDICATIONS AND USAGE OGSIVEO is indicated for adult patients with progressing desmoid tumors who require systemic treatment. OGSIVEO is a gamma secretase inhibitor indicated for adult patients with progressing desmoid tumors who require systemic treatment. ( 1 )